Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Clearances received for the Joint Venture between Metall Zug and Miele


Metall Zug AG / Key word(s): Joint Venture
Clearances received for the Joint Venture between Metall Zug and Miele

05-Jun-2024 / 06:23 CET/CEST
Release of an ad hoc announcement pursuant to Art. 53 LR
The issuer is solely responsible for the content of this announcement.


Ad hoc announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange

Zug, June 5, 2024 – The respective relevant authorities have given their clearance for the Joint Venture between Metall Zug and Miele. The closing is planned for June 7, 2024. After this date, the Joint Venture will commence its operational activities.

As communicated on November 28, 2023, Metall Zug and Miele have signed an agreement under which Metall Zug will contribute its Infection Control Business Unit and the Belimed Life Science Group, and Miele its Steelco Group, into a newly established Joint Venture based in Zug, Switzerland. Metall Zug will participate with 33% and Miele with 67% in the Joint Venture.

The closing of the Joint Venture was subject to the clearance of the respective relevant authorities. These clearances have now been granted, so that the closing is expected to take place on June 7, 2024, and will be communicated on June 10, 2024. The Infection Control Business Unit and the Belimed Life Science Group (part of the Reporting Segment Others) will be fully consolidated in the consolidated financial statements of the Metall Zug Group until the closing. After that, Metall Zug AG's share of the Joint Venture's net result will be reported in the financial result.

About the Metall Zug Group
Metall Zug is a group of industrial companies headquartered in Zug. The Group has around 2,200 employees and comprises four Business Units:

  • Infection Control (Belimed Group)
  • Medical Devices (Haag-Streit Group)
  • Technologycluster Infrastructure (Tech Cluster Zug AG, Urban Assets Zug AG)
  • Others (Belimed Life Science Group, Gehrig Group AG and Metall Zug AG)

The holding company Metall Zug AG is listed in the Swiss Reporting Standard of SIX Swiss Exchange in Zurich (type B registered shares: securities number 3982108, ticker symbol METN).

Legal Notes
The expectations expressed in this announcement are based on assumptions. Actual results may vary from those anticipated. This announcement is published in German and English. The German version is binding. Metall Zug AG processes personal data in accordance with its privacy statement available under: https://www.metallzug.ch/en/datenschutzerklaerung.

Key dates  
August 19, 2024 Publication of Half-year Report 2024
   
Further information  
Urs Scherrer
Chief Financial Officer
Phone: +41 58 768 60 50
Bettine Killmer
Head of Corporate Communications IR
Phone: +41 58 768 60 50

or: [email protected] 

This announcement is available at https://www.metallzug.ch/en/medien/medienmitteilungen.



End of Inside Information

1918083  05-Jun-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1918083&application_name=news&site_id=sharewise~~~202ee175-2c72-4a50-a0f7-89cd8fcfa533
Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments